Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
BeiGene
Stanford University
University of Nebraska
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Mayo Clinic
University of Chicago
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
University of Washington
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
M.D. Anderson Cancer Center
INSYS Therapeutics Inc
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Mayo Clinic